Dr Lisa Lancaster Discusses the Overlap of Sleep Apnea and Lung Diseases

Lisa Lancaster, MD, assistant professor of medicine at Vanderbilt Health, discusses how sleep apnea is a comorbidity for other lung diseases, such as chronic obstructive pulmonary disease (COPD) and interstitial lung disease.

Related Videos

Related Content

Advertisement

August 2nd 2025

US Health Care Disparities in Immunology Biologics Access: A Systematic Review

Grace C. Wright, MD, PhD Ginette A. Okoye, MD Adam C. Ehrlich, MD, MPH D. J. Lorimier, PharmD, MS Shahnaz Khan, MPH Alisha Krumbach, PharmD Catherine Copley-Merriman, MS, MBA Kateryna Onishchenko, PhD Osayi Ovbiosa, PhD Manish Mittal, PhD

This article presents a systematic review of US health care disparities in biologics access across immunology (ie, rheumatology, dermatology, and gastroenterology) and a call to action.

August 2nd 2025

High Costs, Coverage Variability Limit Access to Incretin Mimetics for Weight Management

Brooke McCormick Stephen Lott, PharmD, MS Jonathan Gabison, MD, DABOM

This Managed Care Cast episode explores how high costs and inconsistent insurance coverage for incretin mimetics impact obesity management and patient care.

August 2nd 2025

Bridging the Gaps: New Strategies for Preventing Cardiovascular Disease

Laura Joszt, MA

During the Addressing Cardiovascular Risk and Intervening Early webinar, experts discussed innovative strategies for cardiovascular disease prevention, emphasizing risk assessment, lifestyle changes, and collaborative care to improve patient outcomes.

August 2nd 2025

Why Collaborative Care Is the Path Forward for Mental Health Care: Anna Bobb, MPH

Giuliana Grossi Anna Bobb, MPH

Explore how the Collaborative Care Model enhances mental health access in this episode featuring Anna Bobb, MPH, executive director of the Path Forward coalition.

August 2nd 2025

Taletrectinib Recommended in NCCN Guidelines for ROS1-Positive NSCLC

Rose McNulty

Taletrectinib was added to the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology as a preferred option for the first-line and subsequent treatment of advanced ROS1-positive non–small cell lung cancer (NSCLC).

August 2nd 2025

Progress and Challenges With Gene Therapy in Hereditary Hearing Loss

Rose McNulty

Gene therapy appears to be a promising approach for a subset of genetic deafness, although challenges remain with development and manufacturing.

Related Content

Advertisement

August 2nd 2025

US Health Care Disparities in Immunology Biologics Access: A Systematic Review

Grace C. Wright, MD, PhD Ginette A. Okoye, MD Adam C. Ehrlich, MD, MPH D. J. Lorimier, PharmD, MS Shahnaz Khan, MPH Alisha Krumbach, PharmD Catherine Copley-Merriman, MS, MBA Kateryna Onishchenko, PhD Osayi Ovbiosa, PhD Manish Mittal, PhD

This article presents a systematic review of US health care disparities in biologics access across immunology (ie, rheumatology, dermatology, and gastroenterology) and a call to action.

August 2nd 2025

High Costs, Coverage Variability Limit Access to Incretin Mimetics for Weight Management

Brooke McCormick Stephen Lott, PharmD, MS Jonathan Gabison, MD, DABOM

This Managed Care Cast episode explores how high costs and inconsistent insurance coverage for incretin mimetics impact obesity management and patient care.

August 2nd 2025

Bridging the Gaps: New Strategies for Preventing Cardiovascular Disease

Laura Joszt, MA

During the Addressing Cardiovascular Risk and Intervening Early webinar, experts discussed innovative strategies for cardiovascular disease prevention, emphasizing risk assessment, lifestyle changes, and collaborative care to improve patient outcomes.

August 2nd 2025

Why Collaborative Care Is the Path Forward for Mental Health Care: Anna Bobb, MPH

Giuliana Grossi Anna Bobb, MPH

Explore how the Collaborative Care Model enhances mental health access in this episode featuring Anna Bobb, MPH, executive director of the Path Forward coalition.

August 2nd 2025

Taletrectinib Recommended in NCCN Guidelines for ROS1-Positive NSCLC

Rose McNulty

Taletrectinib was added to the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology as a preferred option for the first-line and subsequent treatment of advanced ROS1-positive non–small cell lung cancer (NSCLC).

August 2nd 2025

Progress and Challenges With Gene Therapy in Hereditary Hearing Loss

Rose McNulty

Gene therapy appears to be a promising approach for a subset of genetic deafness, although challenges remain with development and manufacturing.